NEW ORLEANS, — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company’s securities between February 26, 2018 and February 21, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Diplomat investors should visit us at https://www.claimsfiler.com/cases/view-diplomat-pharmacy-inc-securities-litigation-1 or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuits
Diplomat and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 22, 2019, Diplomat disclosed the postponement of the release of its Q4 and full-year 2018 earnings as it worked to finalize the amount of an impairment charge, which was “expected to be equal to a significant portion of the PBM’s Goodwill and Definite-lived intangible assets, which total approximately $630 million as of December 31, 2018, prior to impairment charges.”
On this news, the price of Diplomat’s shares plummeted over 56%.
The case is Riehm v. Diplomat Pharmacy, Inc. et al, 19-cv-1369.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.